Drug development process and COVID-19 pandemic: Flourishing era of outsourcing

Traditional drug development is a tedious process with involvement of enormous cost and a high attrition rate. Outsourcing drug development services to contract research organizations (CROs) has become an important strategy for cost and risk reduction, capacity building, and data generation. The the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasan, Himika, Singh, Devendra, Reeta, K. H., Gupta, Pooja, Gupta, Yogendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846916/
https://www.ncbi.nlm.nih.gov/pubmed/36537406
http://dx.doi.org/10.4103/ijp.ijp_318_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846916/
https://www.ncbi.nlm.nih.gov/pubmed/36537406
http://dx.doi.org/10.4103/ijp.ijp_318_22

Ejemplares similares